This article was originally published in RAJ Devices
GHTF revises proposed STED document
You may also be interested in...
Boston Scientific’s VP of cardiac rhythm management business in Europe, the Middle East and Africa, Angelo De Rosa, talked to Medtech Insight about opportunities to accelerate digital health transformation during the COVID-19 crisis. See what De Rosa said about it here.
Restricting orphan drug approvals could save the US billions of dollars, study from University of California’s Center for Health Policy and Economics suggests.
The latest application submission news and highlights from the Pink Sheet’s US FDA Performance Tracker.